Bio Solution Co

Bio Solution Co Altman Z-Score

The Altman Z-Score of Bio Solution Co (086820.KQ) as of Oct 27, 2026 is 4.53. In the previous year, Altman Z-Score was 3.89 — a change of 16.37% (higher).

Altman Z-Score

4.53

YoY

16.37%

Last updated:

Altman Z-Score of Bio Solution Co is 2025 4.53 . Altman Z-Score of Bio Solution Co was 2024 3.89 . It decreases by 16.37% higher compared to the previous year.

The Bio Solution Co Altman Z-Score history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Altman Z-Score
Date
Altman Z-Score
Jan 1, 2018
47.52 KRW
Jan 1, 2019
48.41 KRW
Jan 1, 2020
57.18 KRW
Jan 1, 2021
3.48 KRW
Jan 1, 2022
3.25 KRW
Jan 1, 2023
3.15 KRW
Jan 1, 2024
3.89 KRW
Jan 1, 2025
4.53 KRW
The Bio Solution Co Altman Z-Score history
YEARAltman Z-ScoreYoY
4.53+16.37%
3.89+23.59%
3.15-3.12%
3.25-6.64%
3.48-93.91%
57.18+18.13%
48.41+1.87%
47.52-19.01%
58.67-9.18%
64.60-12.31%
73.67—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio Solution Co Stock analysis

What does Bio Solution Co do? Bio Solution Co. Ltd. generates revenue through the manufacturing and distribution of cell therapy products and stem cell applied technologies. The company sells stem water, a cosmetic raw material containing human stem cells with whitening and anti-wrinkling effects, and keratinocyte medication for severe burns. Additionally, it offers chondrocyte therapy for arthritis treatment and develops human tissue models for toxicity and efficacy testing. The primary customers are cosmetic manufacturers and medical institutions seeking advanced therapeutic solutions. The firm's product portfolio includes stem water, keratinocyte medication, and chondrocyte therapy, all leveraging tissue engineering and stem cell technologies. These products target the cosmetic and medical sectors, with stem water appealing to the skincare market and keratinocyte and chondrocyte therapies serving medical applications. The company focuses on developing and commercializing cell-based solutions for both cosmetic and therapeutic uses. Bio Solution Co. Ltd. operates within the cell therapy and stem cell technology sector, providing specialized products that combine tissue engineering with stem cell applications. Its revenue streams are derived from the sale of cosmetic raw materials and medical therapeutics, with an emphasis on innovative, science-backed solutions for skin care and medical treatments. Bio Solution Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio Solution Co stock

Altman Z-Score of Bio Solution Co is 4.53 in 2025.

On Eulerpool you can find the complete historical development of Altman Z-Score Bio Solution Co since 2006 – with annual values, charts, and detailed analysis.

The Altman Z-Score predicts bankruptcy probability using five financial ratios. Scores above 3.0 indicate safety, below 1.8 suggests distress risk.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Bio Solution Co

All Key Metrics — Bio Solution Co